Registered entities
Envisia Therapeutics Inc
Reg. No. 46-3362788United States
Innovation
7 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 244 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Investor mix
5 investors on record; lead investors include Canaan, New Enterprise Associates, Wakefield Group, Morningside; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |